A detailed history of Jackson Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jackson Wealth Management, LLC holds 28,509 shares of ABBV stock, worth $5.13 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
28,509
Holding current value
$5.13 Million
% of portfolio
0.96%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$163.84 - $199.33 $4.67 Million - $5.68 Million
28,509 New
28,509 $5.63 Million
Q1 2024

Jun 11, 2024

BUY
$159.82 - $182.1 $183,153 - $208,686
1,146 New
1,146 $208,000
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $122,542 - $146,960
-886 Reduced 2.74%
31,396 $5.08 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $2.66 Million - $3.05 Million
19,837 Added 159.4%
32,282 $4.33 Million
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $2.78 Million - $3.54 Million
-20,217 Reduced 61.9%
12,445 $1.91 Million
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $4,091 - $5,076
31 Added 0.1%
32,662 $5.3 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $76,382 - $96,646
711 Added 2.23%
32,631 $4.42 Million
Q3 2021

Dec 10, 2021

SELL
$106.4 - $120.78 $266,744 - $302,795
-2,507 Reduced 7.28%
31,920 $38,000
Q2 2021

Aug 03, 2021

BUY
$105.21 - $117.21 $228,305 - $254,345
2,170 Added 6.73%
34,427 $3.88 Million
Q1 2021

Apr 12, 2021

BUY
$102.3 - $112.62 $144,038 - $158,568
1,408 Added 4.56%
32,257 $3.49 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $1.49 Million - $2.01 Million
18,484 Added 149.49%
30,849 $3.31 Million
Q3 2020

Oct 13, 2020

BUY
$85.91 - $100.83 $148,538 - $174,335
1,729 Added 16.26%
12,365 $1.08 Million
Q2 2020

Jul 27, 2020

BUY
$73.37 - $98.18 $780,363 - $1.04 Million
10,636 New
10,636 $1.04 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Jackson Wealth Management, LLC Portfolio

Follow Jackson Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Wealth Management, LLC with notifications on news.